新闻/Reuters/Dualitybio's Next-Generation Her3 Adc Db-1310 Granted FDA Fast Track DesignationDualitybio's Next-Generation Her3 Adc Db-1310 Granted FDA Fast Track DesignationRefinitiv阅读少于1分钟9606Duality Biotherapeutics Inc 9606:DUALITYBIO'S NEXT-GENERATION HER3 ADC DB-1310 GRANTED FDA FAST TRACK DESIGNATIONReuters中国股票亚洲美国股票© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html显示更多登录或创建永久免费帐户以阅读此新闻我们开始吧
